BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ray S, Palui R. Immunotherapy in type 1 diabetes: Novel pathway to the future ahead. World J Diabetes 2024; 15(10): 2022-2035 [PMID: 39493558 DOI: 10.4239/wjd.v15.i10.2022]
URL: https://www.wjgnet.com/1948-9358/full/v15/i10/2022.htm
Number Citing Articles
1
Eugenio Cavalli, Giuseppe Rosario Pietro Nicoletti, Ferdinando Nicoletti. Historically Based Perspective on the Immunotherapy of Type 1 Diabetes: Where We Have Been, Where We Are, and Where We May GoJournal of Clinical Medicine 2025; 14(16): 5621 doi: 10.3390/jcm14165621
2
Rui Wei, Bochao Jia, Shuang Zheng, Xuexue Zhang, Miaoran Wang, Ning Sun, Rui Zhang, Qiuyan Li. Application of monoclonal antibodies in diabetes: A bibliometric analysis from 2004–2024Human Vaccines & Immunotherapeutics 2025; 21(1) doi: 10.1080/21645515.2025.2536910
3
Yazdan Ebrahimpour, Sahbasadat Khatami, Mahsa Saffar, Alireza Fereidouni, Zahra Biniaz, Nafiseh Erfanian, Mohammad Fereidouni. A Comprehensive Review of Novel Advances in Type 1 Diabetes MellitusJournal of Diabetes 2025; 17(8) doi: 10.1111/1753-0407.70120
4
Rahul Mittal, Vedaant Mutha, Eavin A. Valerio, Krish Hirani, Giuliana Arevalo, Ayushi Panchal, Mannat Mittal, Joana RN Lemos, Khemraj Hirani. Emerging role of gene therapy in immune modulation and beta-cell preservation in Type 1 diabetesJournal of Drug Targeting 2025; : 1 doi: 10.1080/1061186X.2025.2522869